Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myostatin and Irisin Levels in Predicting the Outcome of Patients With Systemic Inflammation: A Prospective Observational Study

NCT07476391 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT07476391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07476391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myostatin and Irisin Levels in Predicting the Outcome of Patients With Systemic Inflammation: A Prospective Observational Study
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Completed
Start date
April 20, 2023
Completion date
November 11, 2025
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic inflammatory response syndrome (sirs)